Skip to main content

Edelman Joseph's Form 4 filing

LianBio (LIANY) · filed May 25, 2022

Accession no.
0001062993-22-013535
Filed
May 25, 2022, 6:51 PM ET
Trade date
May 23-25, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $442.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edelman JosephCIK 0001164426Director, 10% Owner
Perceptive Advisors LLCCIK 0001224962Director, 10% Owner
Perceptive Life Sciences Master Fund LtdCIK 0001249675Director, 10% Owner
Perceptive Xontogeny Venture Fund, LPCIK 0001757940Director, 10% Owner
LEV LB Holdings, LPCIK 0001789443Director, 10% Owner
Perceptive Venture Advisors, LLCCIK 0001890130Director, 10% Owner
LEV LB Holdings GP, LLCCIK 0001890132Director, 10% Owner
C2 Life Sciences LLCCIK 0001890152Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 23, 2022American Depositary SharesPPurchaseAcquired+8,700$2.49+$21,6632,498,700Indirect
May 24, 2022American Depositary SharesPPurchaseAcquired+42,551$2.47+$105,100.972,541,251Indirect
May 25, 2022American Depositary SharesPPurchaseAcquired+120,000$2.63+$315,6002,661,251Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)